Kevin J. Forney
Vice President – Business Operations
Kevin J. Forney has over 25 years of experience in the healthcare industry in both the medical device and pharmaceutical segments. Kevin joined Abraxis Bioscience in 2010 as the Director of Strategic Initiatives. Prior to joining Abraxis, he held increasing levels of commercial responsibility at APP Pharmaceuticals, last performing as Marketing Director for their $350 million Critical Care injectable product portfolio, thru and beyond APP’s acquisition by Fresenius Kabi AG in 2008. Kevin led the integration of the $200 million injectable anesthesia portfolio, acquired from AstraZeneca, boosting annual revenues by over 35%. His earlier career experiences consisted of rapid diagnostic program management, new technology development, and veterinary product marketing at Abbott Laboratories’ Diagnostics and Chemical Agricultural Products Divisions.
Kevin holds a B.S. in Mechanical Engineering from University of Illinois and a MBA from the University of Chicago Booth School of Business, with a concentration in finance.